A
1600s – 3 key points in the history of fluid resuscitation:
Discovery of blood circulation (1628):
William Harvey published De Motu Cordis, proving that blood circulates through the body via the heart and blood vessels, overturning Galenic ideas that blood was produced and consumed in tissues.Foundations of intravenous therapy (1656):
Christopher Wren and Robert Boyle performed some of the first intravenous injections in animals using a quill and bladder, introducing substances like wine, ale, and opiates—an early step toward IV drug/fluid administration.First blood transfusions (1660s):
Richard Lower successfully performed animal-to-animal blood transfusions and later animal-to-human transfusions (with Jean-Baptiste Denis), demonstrating that blood could be transferred to treat severe blood loss, though this practice was later restricted due to complications and controversy.
3 key points – Hospital Traumatic Deaths from Life-Threatening Hemorrhage (Shackelford & Eastridge):
Hemorrhage is the leading preventable cause of trauma death:
Across military and civilian data, uncontrolled bleeding is consistently the most common cause of potentially survivable trauma deaths, responsible for a large proportion of early in-hospital mortality (often within the first 24 hours of injury).Most preventable deaths occur early and are time-critical:
Many hemorrhage-related deaths happen soon after arrival (median ~2–3 hours in hospital), meaning survival depends heavily on rapid hemorrhage control, early resuscitation, and minimizing time to definitive surgical or interventional care.Advances in trauma systems and resuscitation improve survival:
Strategies such as damage control resuscitation, balanced blood product transfusion, prehospital blood use, and rapid evacuation (“golden hour” concept) have significantly reduced hemorrhage mortality, but junctional and torso bleeding remain major unresolved challenges.
3 key points – Oxygen debt, cellular energetics, and blood-endothelial failure in hemorrhagic shock:
Oxygen debt drives failure of cellular energy systems:
During shock, depletion of oxygen leads to breakdown of high-energy systems (phosphagen system and glycogen–lactic acid pathways). Rapid repayment of this “oxygen debt” is critical, but the longer and larger the deficit, the harder it becomes to restore normal cellular metabolism and prevent organ failure.Lactate is an imperfect marker of recovery:
Although lactate clearance indicates a shift away from anaerobic metabolism, it does not necessarily mean oxygen debt has been fully repaid. Lactate can normalize while true systemic metabolic debt persists, and current clinical tools cannot precisely measure or confirm full repayment of oxygen debt.Oxygen debt drives endothelial dysfunction and blood failure:
Hypoperfusion causes microcirculatory and endothelial injury (“endotheliopathy”), leading to glycocalyx shedding, inflammation, coagulation imbalance, and microvascular collapse. This progression links shock, coagulopathy, and organ failure—making rapid restoration of perfusion essential to prevent “blood failure.”
3 key points – Hemorrhage and massive transfusion in trauma (Vitale, Maegele & Borgman):
Uncontrolled hemorrhage is a leading cause of trauma death and drives early mortality:
Up to ~50% of trauma deaths are due to bleeding, and severe hemorrhage rapidly leads to the “lethal triad” of coagulopathy, hypothermia, and acidosis, which significantly worsens survival if not rapidly corrected.Early, balanced blood product resuscitation improves survival (MTP concept):
Massive Transfusion Protocols (MTPs), typically delivering RBCs, plasma, and platelets in balanced ratios (e.g., 1:1:1), reduce delays in treatment and have been shown to improve outcomes, especially when blood products are administered early—since even minute delays increase mortality risk.Predicting need for massive transfusion is critical but imperfect:
Definitions of “massive transfusion” vary, leading to inconsistencies. Clinical scoring systems (e.g., ABC score, CAT, PROMMTT-derived measures) aim to identify patients needing rapid blood replacement, but no single model is perfect, making early clinical judgment plus structured protocols essential.
Hemorrhage — 3 key points
Major cause of trauma death: Uncontrolled hemorrhage accounts for up to ~50% of trauma-related mortality and contributes to the “lethal triad” of coagulopathy, hypothermia, and acidosis, which worsens shock and survival risk.
Massive transfusion is hard to define: Traditional definitions (e.g., ≥10 units RBC in 24 hours) are limited by survival bias and incomplete capture of severity; newer models like Resuscitation Intensity (RI) and Critical Administration Threshold (CAT) better reflect real-time bleeding severity and transfusion needs.
Early balanced resuscitation improves outcomes: Rapid activation of massive transfusion protocols (MTPs) and use of balanced blood product ratios (e.g., plasma, platelets, RBCs ~1:1:1) reduce early mortality from exsanguination, while delays in blood delivery significantly increase death risk.
Remote Damage Control Resuscitation (RDCR) — 3 key points
Prehospital extension of damage control principles: RDCR applies hospital-based DCR concepts in the field, focusing on preventing/treating hemorrhagic shock early to avoid irreversible oxygen debt and improve survival before surgical care is reached.
Priority is rapid hemorrhage control + minimal crystalloid use: Core interventions include tourniquets, wound packing, hemostatic agents, and junctional/advanced bleeding control tools, combined with hypotensive resuscitation and reduced crystalloid use to avoid worsening coagulopathy.
Goal is “salvageable physiology” on arrival: RDCR aims to deliver patients to definitive surgical care before severe acidosis, hypothermia, and coagulopathy develop; however, optimal endpoints and monitoring tools (e.g., lactate, StO₂, CRI) are still evolving and require further research.
3 key points from the passage:
Leukoreduction, whole blood, and immunologic trade-offs
Leukoreduction is used to reduce inflammatory and immunomodulatory effects of blood transfusion, but it may also impair platelet function even when “platelet-sparing” filters are used, creating a cost–benefit dilemma.
The U.S. military generally does not leukoreduce low-titer O whole blood, while many civilian centers do.
Low-titer O whole blood is favored in many trauma systems because it simplifies logistics and provides balanced resuscitation (RBCs, plasma, and platelets together), despite risks like Rh(D) alloimmunization, especially in females of childbearing potential where anti-D antibodies could affect future pregnancies.
Component therapy and the physiology of hemostatic resuscitation
Effective hemorrhage management requires balanced use of red cells, plasma, and platelets, as each contributes differently: oxygen delivery and clot structure (RBCs), coagulation factors (plasma), and primary clot formation (platelets).
Storage limitations are clinically important: RBCs develop “storage lesions,” plasma requires thawing or alternative storage forms, and platelets rapidly lose function and are highly susceptible to contamination.
Cold-stored platelets and whole blood are increasingly viewed as superior in trauma settings due to improved hemostatic performance and better logistical suitability, especially in prehospital or resource-limited environments.
Adjuncts and goal-directed resuscitation in hemorrhage care
Hemostatic resuscitation is supported by early use of agents like tranexamic acid (TXA), which reduces mortality when given early, as demonstrated in the CRASH-2 trial.
Calcium replacement is essential during massive transfusion to counter citrate-induced hypocalcemia, improving coagulation and cardiac function.
Advanced approaches (e.g., viscoelastic testing, fibrinogen concentrates, PCCs) are promising but not yet fully validated, reinforcing that early empiric balanced transfusion remains the core strategy in modern trauma care, including protocols used in systems like Tactical Combat Casualty Care.#
3 key points:
Cryopreservation process and mechanisms
Frozen red blood cell (fRBC) preservation involves three steps: glycerolization, storage, and deglycerolization.
Glycerol acts as a cryoprotectant by entering RBCs and binding intracellular water, preventing ice formation and reducing salt-driven hypertonic damage.
Two main methods exist: high glycerol (HGC) (−80 °C storage, long shelf life up to decades) and low glycerol (LGC) (faster cooling in liquid nitrogen, less hemolysis but more complex handling).
Processing technology and clinical usability
Before transfusion, glycerol must be removed through deglycerolization (washing with saline solutions), historically taking hours but now reduced to ~2 hours using automated systems.
Modern systems like the ACP 215 closed system allow sterile processing, longer post-thaw storage (up to 7–14 days), and improved logistics.
Despite improvements, processing still requires specialized equipment and handling before transfusion.
Clinical advantages of frozen red blood cells
Inventory and supply resilience: fRBCs can be stored for years, helping offset donor shortages, seasonal fluctuations, and disaster-related surges.
Reduced storage lesion effects: freezing halts metabolic degradation, preserving ATP, 2,3-DPG, and reducing inflammatory byproducts that accumulate in liquid-stored blood.
Additional benefits: improved access to rare blood types, reduced pathogen transmission risk (historically important), and potential improvements in tissue oxygenation and inflammatory profiles in trauma transfusion studies.
No comments:
Post a Comment